Colgate-Palmolive Co. (CL)
Oversold Conditions For Colgate-Palmolive
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend King Down 26% to Buy Right Now
First things first, most Dividend Kings (stocks that have increased dividends for at least 50 years in a row) won't provide investors with multibagger returns anytime soon.
Will Colgate's Strategic Efforts and Innovation Bolster Growth?
CL powers growth with pricing strength, cost savings, premium innovation and AI-driven supply-chain agility.
Buy CL Stock At $80?
Colgate-Palmolive stock (NYSE: CL) has decreased by 12% this year, lagging behind the S&P 500, which has risen by 13%. This drop is primarily attributed to various factors, such as slowing sales growth, with the company projecting only about 2% organic sales growth for 2025.
Colgate-Palmolive: A Defensive Staple With Meaningful Upside
Colgate-Palmolive remains a global leader in oral care, boasting strong brand equity, innovation, and a 62-year dividend growth streak. CL demonstrates resilience amid inflation, with robust margins, an improving debt profile, and potential for further growth in emerging markets and sustainable products. DCF analysis and analyst consensus suggest CL is fairly valued but offers 15% upside, supported by a 'Buy' rating from most analysts.
Here's Why Colgate-Palmolive (CL) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Can Colgate's New Productivity Program Drive Long-Term Growth?
Colgate launches a $300-$400M productivity program to boost efficiency, cut costs and fuel long-term growth amid market pressures.
Colgate-Palmolive Company (CL) Presents At Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript
Colgate-Palmolive Company (NYSE:CL ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 3, 2025 9:00 AM EDT Company Participants Noel Wallace - Chairman, CEO & President Conference Call Participants Lauren Lieberman - Barclays Bank PLC, Research Division Presentation Lauren Lieberman MD & Senior Research Analyst Okay. We're going to get started.
Why Colgate-Palmolive (CL) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Will Colgate's Innovation Drive Market Share Gains in 2025?
CL's innovation push spans premium oral, personal, home and pet care to drive market share growth in 2025 despite headwinds.
3 Bargain-Basement Dividend Stocks to Buy Now Before Their Discounts Disappear
Key Points in This Article: Consumer staple stocks provide stability due to consistent demand for essential goods, making them reliable investments in any market.
Colgate-Palmolive Company (CL) Q2 2025 Earnings Call Transcript
Colgate-Palmolive Company (NYSE:CL ) Q2 2025 Earnings Conference Call August 1, 2025 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer and Executive VP of M&A Noel R. Wallace - Chairman, CEO & President Stanley J.
